Aaron H. Colby

Boston University — United States

Materials Science · Physical Sciences

23h-index1.2kcitations50works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(16), Graphene and Nanomaterials Applications(7), Cancer Treatment and Pharmacology(5), Pancreatic and Hepatic Oncology Research(4), Microbial Natural Products and Biosynthesis(4)

Publications50 total

Endolysosome-targeted nanoparticle delivery of antiviral therapy for coronavirus infections
Life Science Alliance·2025· 2 citedOpen Access
Verticillin A-Loaded Surgical Buttresses Prevent Local Pancreatic Cancer Recurrence in a Murine Model
Molecular Pharmaceutics·2025· 2 citedOpen Access
Author Reply to Peer Reviews of ENDO-LYSOSOME-TARGETED NANOPARTICLE DELIVERY OF ANTIVIRAL THERAPY FOR CORONAVIRUS INFECTIONS
2023· 1 cited
Endo-Lysosome-Targeted Nanoparticle Delivery of Antiviral Therapy for Coronavirus Infections
2023· 3 citedOpen Access
Supplementary Data from Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage
2023Open Access
Data from Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
2023Open Access
Data from Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
2023Open Access
Supplementary Figure from Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
2023Open Access
Supplementary Data from Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage
2023Open Access
Data from Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage
2023Open Access
Supplementary Figure from Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
2023Open Access
Data from Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage
2023Open Access
Radiolabeled Biodistribution of Expansile Nanoparticles: Intraperitoneal Administration Results in Tumor Specific Accumulation
ACS Nano·2023· 28 citedOpen Access
pH-Responsive nanofiber buttresses as local drug delivery devices
Biomaterials Science·2022· 26 citedOpen Access
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
Molecular Cancer Therapeutics·2022· 1 citedOpen Access
Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth <i>In Vivo</i>
ACS Nano·2022· 34 citedOpen Access
H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth
Oncogene·2022· 25 citedOpen Access
G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes
Journal for ImmunoTherapy of Cancer·2022· 30 citedOpen Access
Pilot-scale production of expansile nanoparticles: Practical methods for clinical scale-up
Journal of Controlled Release·2021· 38 citedOpen Access
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
The Journal of Immunology·2021· 110 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Mark W. Grinstaff(49), Yolonda L. Colson(24), Cedric J. Pearce(20), Nicholas H. Oberlies(19), Kebin Liu(11), Joanna E. Burdette(9), Dafeng Yang(8), John D. Klement(7), Zachary Mattes(7), Orian S. Shirihai(6), William A. Blessing(6), Chunwan Lu(5), Victoria L. M. Herrera(5), Rong Liu(5), Amrita Salvi(5), Chiraz Soumia M. Amrine(5), Julia R. Austin(5), KiAundra Kilpatrick(5), Daniel D. Lantvit(5), Esther L. Calderon-Gierszal(5)